[go: up one dir, main page]

FR2564320B1 - METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE - Google Patents

METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE

Info

Publication number
FR2564320B1
FR2564320B1 FR8407746A FR8407746A FR2564320B1 FR 2564320 B1 FR2564320 B1 FR 2564320B1 FR 8407746 A FR8407746 A FR 8407746A FR 8407746 A FR8407746 A FR 8407746A FR 2564320 B1 FR2564320 B1 FR 2564320B1
Authority
FR
France
Prior art keywords
vaccine
antirabic
tumorous
producing
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8407746A
Other languages
French (fr)
Other versions
FR2564320A1 (en
Inventor
Florian Horaud
Pierre Sureau
Pierre Perrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR8407746A priority Critical patent/FR2564320B1/en
Publication of FR2564320A1 publication Critical patent/FR2564320A1/en
Application granted granted Critical
Publication of FR2564320B1 publication Critical patent/FR2564320B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation
    • C12N2760/20164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8407746A 1984-05-18 1984-05-18 METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE Expired FR2564320B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8407746A FR2564320B1 (en) 1984-05-18 1984-05-18 METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8407746A FR2564320B1 (en) 1984-05-18 1984-05-18 METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE

Publications (2)

Publication Number Publication Date
FR2564320A1 FR2564320A1 (en) 1985-11-22
FR2564320B1 true FR2564320B1 (en) 1986-10-17

Family

ID=9304133

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8407746A Expired FR2564320B1 (en) 1984-05-18 1984-05-18 METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE

Country Status (1)

Country Link
FR (1) FR2564320B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1207005C (en) 2002-10-31 2005-06-22 威世药业（如皋）有限公司 Rabbit skin containing bioactive substance and its use

Also Published As

Publication number Publication date
FR2564320A1 (en) 1985-11-22

Similar Documents

Publication Publication Date Title
PH16533A (en) Method for producing ethanol in high concentration by using immobilized microorganis
BE891930A (en) HYDROGEL FORMING ARTICLES, HARD CONTACT LENS AND METHOD FOR PRODUCING HYDROGEL FORMING ARTICLE
FR2415094B1 (en) PROCESS FOR PRODUCING N, N-DI (ETHYL) -META-TOLUAMIDE
BE878902A (en) PROCESS FOR PRODUCING ALKYLENE-GLYCOLS
BR8405314A (en) PROCESS FOR PRODUCTION OF ETHANOL BY FERMENTATION
PH16391A (en) Continuous fermentation process for producing ethanol
FR2599386B1 (en) SUSTAINABLE ELECTRODES FOR ELECTROLYSIS AND METHOD FOR THE PRODUCTION THEREOF
FR2421170B1 (en) PROCESS FOR THE PREPARATION OF 2,2,6,6-TETRAMETHYL-4-PIPERIDONE
AR222649A1 (en) METHOD FOR THE PRODUCTION OF ETHANOL, BY CONTINUOUS FERMENTATION
BG41125A3 (en) Method for preparing benzamides
FR2567148B1 (en) PROCESS FOR OBTAINING METHANE BY FERMENTATION OF ALGAE
BE890409A (en) PROCESS FOR PRODUCING POLYISOBUTENES
FR2298002A1 (en) PROCESS FOR ENERGY PRODUCTION
BE880416A (en) IMPROVED PROCESS FOR THE PRODUCTION OF ETHANOL BY FERMENTATION
IT1107693B (en) PROCESS FOR THE PRODUCTION OF BOTTLES
BE888562A (en) PROCESS FOR PRODUCING AN ENZYMATIC PREPARATION OF FRUCTOSYL-TRANSFERASE,
FR2564320B1 (en) METHOD FOR PRODUCING ANTIRABIC VACCINE ON NON-TUMOROUS RABBIT CELL LINE CULTURES, ANTIRABIC VACCINE OBTAINED BY THIS PROCESS AND NOVEL CELL LINES FOR USE IN THE PRODUCTION OF SAID VACCINE
FR2306263A1 (en) IMPROVED PROCESS FOR PRODUCING UROKINASE
BE876083A (en) PROCESS FOR IMPROVING THE HARDNESS OF AN AGGREGATE OF BACTERIAL CELLS
FR2539760B1 (en) PROCESS FOR THE PRODUCTION OF METHANE BY ANAEROBIC FERMENTATION
FR2464226B1 (en) PROCESS FOR PRODUCING DIAMONDS AND DIAMONDS OBTAINED BY SAID PROCESS
BE826886A (en) PROCESS FOR OBTAINING CONTINUOUS LINES OF TUMOR CELLS IN VITRO
IT1146917B (en) PROCESS FOR THE PRODUCTION OF AMINOARYL-BETA-SULPHATEETHYL-SULPHONE
YU61982A (en) Process for producing intermediates useful in the production of 1,1-dioxo-penicillanoyloxy-methyl-6-(2-amino-2-phenylacetamido0penicillanate
FR2316245A1 (en) PROCESS FOR OBTAINING UROKINASE

Legal Events

Date Code Title Description
ST Notification of lapse